Evidence map›Paper›PMID 26862167›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation.

Takamitsu Hattori, Darson Lai, Irina S Dementieva, Sherwin P Montaño, Kohei Kurosawa, Yupeng Zheng, Louesa R Akin, Kalina M Świst-Rosowska, Adrian T Grzybowski, Akiko Koide and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Binding mode-guided development of high-performance antibodies targeting site-specific posttranslational modifications.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Engineering Binders with Exceptional Selectivity.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review:Frontiers in genetics · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Takamitsu HattoriDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637;
Darson LaiDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637;
Irina S DementievaDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637;
Sherwin P MontañoDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637;
Kohei KurosawaDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637;
Yupeng ZhengDepartment of Chemistry, Northwestern University, Evanston, IL 60208; Department of Molecular Biosciences, Northwestern University, Evanston, IL 60208; Chemistry of Life Processes Institute, Northwestern University, Evanston, IL 60208;
Louesa R AkinDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637;
Kalina M Świst-RosowskaDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637; Department of Biochemistry, Faculty of Chemistry, Wrocław University of Technology, 50-370, Wrocław, Poland;
Adrian T GrzybowskiDepartment of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL 60637;
Akiko KoideDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637;
Krzysztof KrajewskiDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599.
Brian D StrahlDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599.
Neil L KelleherDepartment of Chemistry, Northwestern University, Evanston, IL 60208; Department of Molecular Biosciences, Northwestern University, Evanston, IL 60208; Chemistry of Life Processes Institute, Northwestern University, Evanston, IL 60208;
Alexander J RuthenburgDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637; Department of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL 60637;
Shohei KoideDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637; skoide@uchicago.edu.
University of Chicago · USNorthwestern University · USUniversity of North Carolina at Chapel Hill · USWrocław University of Science and Technology · PL

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1M
Eukaryotic Post-Translational ModificationsR01GM067193 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KELLEHER, NEIL L · 2003 to 2015
$4.0M
Renewable synthetic antibodies for epigenomicsRC1DA028779 · NIDA · UNIVERSITY OF CHICAGO · PI KOIDE, SHOHEI · 2009 to 2010
$1.0M
Novel affinity reagents for epigenetics markersR21DA025725 · NIDA · UNIVERSITY OF CHICAGO · PI KOIDE, SHOHEI · 2008 to 2009
$604k
NCI NIH HHS P30 CA014599NCI NIH HHS P30 CA060553NIDA NIH HHS R21 DA025725NIDA NIH HHS RC1 DA028779NIGMS NIH HHS GM067193NIGMS NIH HHS R01 GM067193
6 · The paper itself

Abstract

Antibodies have a well-established modular architecture wherein the antigen-binding site residing in the antigen-binding fragment (Fab or Fv) is an autonomous and complete unit for antigen recognition. Here, we describe antibodies departing from this paradigm. We developed recombinant antibodies to trimethylated lysine residues on histone H3, important epigenetic marks and challenging targets for molecular recognition. Quantitative characterization demonstrated their exquisite specificity and high affinity, and they performed well in common epigenetics applications. Surprisingly, crystal structures and biophysical analyses revealed that two antigen-binding sites of these antibodies form a head-to-head dimer and cooperatively recognize the antigen in the dimer interface. This "antigen clasping" produced an expansive interface where trimethylated Lys bound to an unusually extensive aromatic cage in one Fab and the histone N terminus to a pocket in the other, thereby rationalizing the high specificity. A long-neck antibody format with a long linker between the antigen-binding module and the Fc region facilitated antigen clasping and achieved both high specificity and high potency. Antigen clasping substantially expands the paradigm of antibody-antigen recognition and suggests a strategy for developing extremely specific antibodies.

Indexed as

Binding Sites, AntibodyAntibodies, MonoclonalAntigensCrystallography, X-RayHistonesHumansImmunoglobulin Fab FragmentsMethylationProtein Structure, QuaternaryAntibodies, MonoclonalAntigensHistonesImmunoglobulin Fab Fragmentsantibody engineeringantibody validationdata reproducibilityepigeneticsprotein–protein interaction

Identifiers

PMID26862167
PMCPMC4776465
OpenAlexW2267040464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.